AlphaGenome Atlas, Google DeepMind's new 1-petabyte genomics database, pre-computes predicted molecular effects for all 9 ...

What happens when the cellular machinery making therapeutic proteins slows down? New research in Nature shows why translation ...

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing ...

Dyne Therapeutics lead asset z-rostudirsen faces regulatory and confirmatory risks, with FDA approval likely. Find out why ...

RNAV8 will be part of a team led by the Rouskin Lab at Harvard Medical School with the Weissman Lab at MIT/the Whitehead ...

Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the appointment of Nicole ...

RNA-based therapeutics use RNA as a blueprint that enables cells to produce specific proteins—including proteins that can ...

Explore the preclinical research catching our eye in September 2026, from siRNA and in vivo CRISPR to targeted protein ...

Editas Medicine (NASDAQ:EDIT) is preparing to begin a first-in-human study of EDIT-401, an in vivo CRISPR-edited medicine designed to lower LDL cholesterol in patients with heterozygous familial ...

Single-cell RNA sequencing (scRNA-seq) is a method to measure gene expression of individual cells, allowing observation of ...

A new RNA search engine can scan millions of cells in seconds for mutations, pathogens, isoforms and other biological clues.